Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2014
10/14/2014US8859218 In situ detection of early stages and late stages HPV infection
10/14/2014US8859211 Immunodisplacement electrophoresis
10/14/2014US8859209 Reimmunization and antibody design
10/14/2014US8859205 Methods and compositions for improving efficiency of nucleic acids amplification reactions
10/14/2014US8858957 GAS57 mutant antigens and GAS57 antibodies
10/14/2014US8858951 Compositions for eliciting an immune response
10/14/2014US8858950 Delivery of pharmaceutical agents via the human insulin receptor
10/14/2014US8858949 Antibodies that specifically bind to a beta oligomers and use thereof
10/14/2014US8858947 Hepatitis C antibodies and uses thereof
10/14/2014US8858946 Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
10/14/2014US8858945 Three-dimensional structure of complement receptor type 2 and uses thereof
10/14/2014US8858944 Treatment drug for autoimmune diseases and allergic diseases
10/14/2014US8858943 Antigen binding proteins
10/14/2014US8858942 Antibodies directed to ERBB2
10/14/2014US8858941 VEGF/DLL4 binding agents and uses thereof
10/14/2014US8858940 Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
10/14/2014US8858938 Human monoclonal antibodies against Hendra and Nipah viruses
10/14/2014US8858937 Optimized Fc variants and methods for their generation
10/14/2014US8858935 Compositions and methods for increasing the stability of antibodies
10/14/2014US8858912 Frozen compositions and methods for piercing a substrate
10/09/2014WO2014165818A2 Compositions and methods for preventing and treating prostate cancer
10/09/2014WO2014165746A1 Methods and compositions using adam10 inhibitors to treat bacterial infections
10/09/2014WO2014165282A1 Immunologically active polypeptide
10/09/2014WO2014165119A1 Cyclodextrin and antibody-drug conjugate formulations
10/09/2014WO2014165115A1 Humanized anti-n2 antibodies
10/09/2014WO2014165103A1 Individualized high-purity glioblastoma multiforme stem cells and methods for stimulating immune response
10/09/2014WO2014165028A1 Antibodies specific to a novel epitope on cemx of human membrane-bound ige and uses thereof in treating ige-mediated diseases
10/09/2014WO2014164959A2 Anti-il-33 antibodies and uses thereof
10/09/2014WO2014164727A1 A method of treating fungal infection
10/09/2014WO2014164693A2 Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
10/09/2014WO2014164680A1 Cd20-binding immunotoxins for inducing cellular internalization and methods using same
10/09/2014WO2014164553A1 Antigen binding constructs to cd8
10/09/2014WO2014164544A1 Vascular-targeted t-cell therapy
10/09/2014WO2014164503A1 Hyperglycosylated binding polypeptides
10/09/2014WO2014163344A1 Peptide for diagnosing ovarian granulosa tumor cells and use thereof
10/09/2014WO2014163101A1 Fc region variant
10/09/2014WO2014162102A1 Novel mycobacterium tuberculosis target and use thereof in the screening of anti-tuberculosis drugs
10/09/2014WO2014161940A1 A method for increasing pyro-glutamic acid formation of a protein
10/09/2014WO2014161887A1 Targeted cancer immune therapy
10/09/2014WO2014161845A1 Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use
10/09/2014WO2014161570A1 Antibodies against human il17 and uses thereof
10/09/2014WO2014161509A1 Novel pd1 isoforms, and uses thereof for potentiating immune responses
10/09/2014WO2014161483A1 Broad spectrum monoclonal antibody identifying ha1 structural domain of influenza virus hemagglutinin proteins
10/09/2014WO2014161095A1 Crp40 fragments for the treatment of neurological disorders
10/09/2014WO2014161037A1 Antibodies against human ryk and uses therefor
10/09/2014US20140304846 Gene and mutations thereof associated with seizure and movement disorders
10/09/2014US20140303358 Osteogenesis Promoter
10/09/2014US20140303356 Production of heterodimeric proteins
10/09/2014US20140303355 Humanized Anti-Factor D Antibodies And Uses Thereof
10/09/2014US20140303354 Anti-CD47 Antibodies and Methods of Use Thereof
10/09/2014US20140303020 Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor
10/09/2014US20140302618 Clozapine Immunoassay
10/09/2014US20140302598 Human antibodies specifically binding to the hepatitis b virus surface antigen
10/09/2014US20140302581 Methods for enhanced protein production
10/09/2014US20140302527 Target-specific probe comprising ferritin protein and detection for biomarker using the same
10/09/2014US20140302517 Anti-idiotype antibody against anti-c-met antibody
10/09/2014US20140302511 Cancer stem cell-specific molecule
10/09/2014US20140302499 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
10/09/2014US20140302144 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
10/09/2014US20140302129 Human lubrication gel
10/09/2014US20140302122 Fungal-specific metalloproteases and uses thereof
10/09/2014US20140302082 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 1b, hepatitis c virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis c virus particles
10/09/2014US20140302074 Pat-LM1 Epitopes and Methods for Using Same
10/09/2014US20140302070 Novel pd1 isoforms, and uses thereof for potentiating immune responses
10/09/2014US20140302064 Optimized anti-cd3 variable regions
10/09/2014US20140302063 Influenza virus antibody compositions
10/09/2014US20140302062 Herpes simplex virus
10/09/2014US20140302061 Biomarkers for tslp treatment
10/09/2014US20140302059 Compositions and methods for cancer and cancer stem cell detection and elimination
10/09/2014US20140302058 Human anti il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
10/09/2014US20140302057 Inhibitors of metastasis
10/09/2014US20140302055 Antibodies Directed to Angiopoietin-like Protein 4 and Uses Thereof
10/09/2014US20140302054 Anti-gpr49 antibodies
10/09/2014US20140302053 Compositions for the treatment of rheumatoid arthritis and methods of using same
10/09/2014US20140302050 Targeting an amphiregulin-derived cell surface neo-epitope
10/09/2014US20140302049 Anti-gpr49 antibodies
10/09/2014US20140302048 Plasma kallikrein binding proteins
10/09/2014US20140302047 Thrombin-binding antibody molecules and uses thereof
10/09/2014US20140302046 Immunological Targeting of Pathological Tau Proteins
10/09/2014US20140302045 Igy composition for use in celiac disease
10/09/2014US20140302044 Mcpip protection against osteoclast production
10/09/2014US20140302043 Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
10/09/2014US20140302041 Anti-axl antibodies and uses thereof
10/09/2014US20140302040 Novel Antibodies and Uses Thereof
10/09/2014US20140302038 Multispecific and multivalent binding proteins and uses thereof
10/09/2014US20140302037 BISPECIFIC-Fc MOLECULES
10/09/2014US20140302036 Proteins specific for baff and b7rp1
10/09/2014US20140302035 ANTI-C-MET Tandem Fc Bispecific Antibodies
10/09/2014US20140302034 Novel modulators and methods of use
10/09/2014US20140302033 Albumin binding antibodies and binding fragments thereof
10/09/2014US20140302032 Monoclonal antibodies for tumor treatment
10/09/2014US20140302031 Targeting abcb5 for cancer therapy
10/09/2014US20140302029 Anti-c-met/anti-egfr bispecific antibodies
10/09/2014US20140302028 Fc containing polypeptides having increased anti-inflammatory properties and increased fcrn binding
10/09/2014US20140302024 Serum amyloid p-antibody fusion proteins
10/09/2014US20140302021 Antibody formulations and methods
10/09/2014US20140302020 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
10/09/2014US20140302018 Treatment of diffuse large-cell lymphoma with anti-cd20 antibody
10/09/2014US20140302016 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
10/09/2014US20140302015 Antibodies against human il33r and uses thereof
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 1494